首页 > 最新文献

Current Opinion in Ophthalmology最新文献

英文 中文
Lifestyle modifications and environmental risk factors for glaucoma. 青光眼的生活方式改变和环境风险因素。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-03-01 Epub Date: 2024-10-23 DOI: 10.1097/ICU.0000000000001098
Abdelrahman M Elhusseiny, Ahmad A Aref

Purpose of review: To summarize recent evidence about the association between different lifestyle modifications and environmental risk factors and glaucoma.

Recent findings: Incorporating moderate exercise into the routine of glaucoma patients may help slow the progression of the condition. However, caution should be taken when using swim goggles, and it may be advisable to avoid certain yoga positions and heavy weight-lifting exercises, as they have been linked to intraocular pressure (IOP) spikes and potential risks for glaucoma patients. Various relaxation techniques may lower IOP. The evidence remains inconclusive about the association between vitamins intake and glaucoma. Dietary nitric oxide has been associated with a lower risk of glaucoma. Higher smoking intensity has been linked to faster visual field decline and retinal nerve fiber layer thinning. Additionally, there is currently insufficient evidence to support the use of marijuana in managing glaucoma, with side effects outweighing the proposed benefits. A significant association has been found between air pollutants and ganglion cell layer thinning, as well as a greater burden of glaucoma.

Summary: Lifestyle and environmental factors are increasingly recognized as significant contributors to glaucoma development and progression. These modifications should be integrated into a comprehensive treatment approach alongside medications or surgical interventions.

综述的目的:总结有关不同生活方式的改变和环境风险因素与青光眼之间关系的最新证据:将适度运动纳入青光眼患者的日常生活习惯可能有助于减缓病情的发展。然而,在使用泳镜时应小心谨慎,最好避免某些瑜伽姿势和举重运动,因为它们与眼压飙升和青光眼患者的潜在风险有关。各种放松技巧可降低眼压。关于维生素摄入量与青光眼之间的关系,目前尚无定论。膳食中的一氧化氮与降低青光眼风险有关。较高的吸烟强度与较快的视野下降和视网膜神经纤维层变薄有关。此外,目前还没有足够的证据支持使用大麻来治疗青光眼,因为大麻的副作用超过了所建议的益处。总结:生活方式和环境因素越来越被认为是导致青光眼发生和发展的重要因素。这些改变应与药物或手术干预一起纳入综合治疗方法中。
{"title":"Lifestyle modifications and environmental risk factors for glaucoma.","authors":"Abdelrahman M Elhusseiny, Ahmad A Aref","doi":"10.1097/ICU.0000000000001098","DOIUrl":"10.1097/ICU.0000000000001098","url":null,"abstract":"<p><strong>Purpose of review: </strong>To summarize recent evidence about the association between different lifestyle modifications and environmental risk factors and glaucoma.</p><p><strong>Recent findings: </strong>Incorporating moderate exercise into the routine of glaucoma patients may help slow the progression of the condition. However, caution should be taken when using swim goggles, and it may be advisable to avoid certain yoga positions and heavy weight-lifting exercises, as they have been linked to intraocular pressure (IOP) spikes and potential risks for glaucoma patients. Various relaxation techniques may lower IOP. The evidence remains inconclusive about the association between vitamins intake and glaucoma. Dietary nitric oxide has been associated with a lower risk of glaucoma. Higher smoking intensity has been linked to faster visual field decline and retinal nerve fiber layer thinning. Additionally, there is currently insufficient evidence to support the use of marijuana in managing glaucoma, with side effects outweighing the proposed benefits. A significant association has been found between air pollutants and ganglion cell layer thinning, as well as a greater burden of glaucoma.</p><p><strong>Summary: </strong>Lifestyle and environmental factors are increasingly recognized as significant contributors to glaucoma development and progression. These modifications should be integrated into a comprehensive treatment approach alongside medications or surgical interventions.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"115-121"},"PeriodicalIF":3.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New treatments for glaucoma. 青光眼的新疗法。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-03-01 Epub Date: 2025-01-09 DOI: 10.1097/ICU.0000000000001110
Anthony P Mai, Tanner J Ferguson, Nathan Radcliffe

Purpose of review: This review highlights new Federal Drug Administration (FDA) approved glaucoma treatments to familiarize providers with immediately available options.

Recent findings: New FDA-approved treatments include the bimatoprost implant, travoprost implant, direct selective laser trabeculoplasty (DSLT), and ocular pressure adjusting pump. The bimatoprost implant is approved for a single administration with effects lasting for about 1 year, as opposed to the nearly 3-year effect for the travoprost implant. Meanwhile, the DSLT lowers intraocular pressure (IOP) by applying a laser through the limbus within 2 s. Lastly, the ocular pressure adjusting pump is a noninvasive, nonpharmaceutical device that lowers IOP with negative pressure within a pair of goggles. Not only do these modalities lower IOP, but they also improve the patient experience by reducing drop burden, decreasing laser duration, or lowering side effects. Although the list of therapies still in development is extensive, another two promising devices under review include a supraciliary stent and an adjustable aqueous tube shunt.

Summary: Glaucoma treatment has considerably evolved over the last decade with the introduction of novel topical medications, minimally invasive glaucoma surgeries, sustained-release drug delivery systems, and wearable devices. This expansion in glaucoma has enabled more patient-centric decision-making regarding treatment.

综述目的:本综述强调了美国联邦药物管理局(FDA)批准的新的青光眼治疗方法,以使提供者熟悉立即可用的选择。最新发现:fda批准的新疗法包括比马前列素植入物、曲伏前列素植入物、直接选择性激光小梁成形术(DSLT)和眼压调节泵。比马前列素植入物被批准为单次给药,效果持续约1年,而曲伏前列素植入物的效果持续近3年。同时,DSLT通过在2秒内通过角膜缘照射激光来降低眼压。最后,眼压调节泵是一种无创、非药物装置,可在一副护目镜内以负压降低眼压。这些方法不仅可以降低IOP,而且还可以通过减少眼压、缩短激光持续时间或降低副作用来改善患者的体验。尽管仍在开发的治疗方法有很多,但另外两种有前景的设备正在审查中,包括辅助支架和可调节的水管分流器。摘要:青光眼的治疗在过去十年中有了很大的发展,引入了新的局部药物,微创青光眼手术,缓释药物输送系统和可穿戴设备。青光眼的扩大使得治疗决策更加以患者为中心。
{"title":"New treatments for glaucoma.","authors":"Anthony P Mai, Tanner J Ferguson, Nathan Radcliffe","doi":"10.1097/ICU.0000000000001110","DOIUrl":"10.1097/ICU.0000000000001110","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review highlights new Federal Drug Administration (FDA) approved glaucoma treatments to familiarize providers with immediately available options.</p><p><strong>Recent findings: </strong>New FDA-approved treatments include the bimatoprost implant, travoprost implant, direct selective laser trabeculoplasty (DSLT), and ocular pressure adjusting pump. The bimatoprost implant is approved for a single administration with effects lasting for about 1 year, as opposed to the nearly 3-year effect for the travoprost implant. Meanwhile, the DSLT lowers intraocular pressure (IOP) by applying a laser through the limbus within 2 s. Lastly, the ocular pressure adjusting pump is a noninvasive, nonpharmaceutical device that lowers IOP with negative pressure within a pair of goggles. Not only do these modalities lower IOP, but they also improve the patient experience by reducing drop burden, decreasing laser duration, or lowering side effects. Although the list of therapies still in development is extensive, another two promising devices under review include a supraciliary stent and an adjustable aqueous tube shunt.</p><p><strong>Summary: </strong>Glaucoma treatment has considerably evolved over the last decade with the introduction of novel topical medications, minimally invasive glaucoma surgeries, sustained-release drug delivery systems, and wearable devices. This expansion in glaucoma has enabled more patient-centric decision-making regarding treatment.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"135-139"},"PeriodicalIF":3.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overlap syndrome: a case series and literature review of concurrent pigment dispersion and pseudoexfoliation syndromes. 重叠综合征:并发色素分散和假性剥脱综合征的病例系列和文献综述。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-03-01 Epub Date: 2024-11-07 DOI: 10.1097/ICU.0000000000001107
Pooja Shah, Srinath Soundararajan, David Fleischman

Purpose of review: The purpose of this review is to present two cases of overlap syndrome, or concurrent pigment dispersion syndrome and pseudoexfoliation syndrome. The summary of existing literature highlights the importance of accurate diagnosis and potential treatment options of overlap syndrome.

Recent findings: The cases describe two patients with overlap syndrome and resulting progressive glaucoma. The condition tends to present after age 50 years old, with presence of both pseudoexfoliative material and pigment dispersion signs. The pigment dispersion syndrome may be quiescent at the time of pseudoexfoliation onset and may have gone undiagnosed. This form of glaucoma poses challenges in controlling intraocular pressure and may progress rapidly, often requiring surgical intervention.

Summary: This paper reviews the common examination findings of pigment dispersion syndrome and pseudoexfoliation, which may aid clinicians in the diagnosis of the rare condition, overlap syndrome. The connection between the two conditions remains unclear, though studies of possible genetic associations are underway. The two-hit theory, or initial damage to the trabecular meshwork increasing susceptibility to future damage, is plausible given the severe nature of the condition. Though definitive conclusions regarding treatment strategies and outcomes of overlap syndrome are lacking, increased awareness, diagnosis, and study of the condition may help guide the management of overlap syndrome.

综述的目的:本综述旨在介绍两例重叠综合征或并发色素分散综合征和假性剥脱综合征的病例。对现有文献的总结强调了准确诊断的重要性以及重叠综合征的潜在治疗方案:这些病例描述了两名患有重叠综合征并导致进展性青光眼的患者。该病多在 50 岁以后发病,同时伴有假性角膜剥脱物和色素分散征。色素分散综合征在假性角膜外翻发病时可能处于静止状态,也可能未被诊断出来。总结:本文回顾了色素分散综合征和假性角膜外翻的常见检查结果,这可能有助于临床医生诊断重叠综合征这一罕见疾病。这两种疾病之间的联系仍不清楚,但可能的遗传关联研究正在进行中。鉴于该病的严重性,"两击理论"(即小梁网最初的损伤增加了未来损伤的易感性)是可信的。虽然目前还没有关于重叠综合征治疗策略和结果的明确结论,但提高对这种疾病的认识、诊断和研究可能有助于指导重叠综合征的治疗。
{"title":"Overlap syndrome: a case series and literature review of concurrent pigment dispersion and pseudoexfoliation syndromes.","authors":"Pooja Shah, Srinath Soundararajan, David Fleischman","doi":"10.1097/ICU.0000000000001107","DOIUrl":"10.1097/ICU.0000000000001107","url":null,"abstract":"<p><strong>Purpose of review: </strong>The purpose of this review is to present two cases of overlap syndrome, or concurrent pigment dispersion syndrome and pseudoexfoliation syndrome. The summary of existing literature highlights the importance of accurate diagnosis and potential treatment options of overlap syndrome.</p><p><strong>Recent findings: </strong>The cases describe two patients with overlap syndrome and resulting progressive glaucoma. The condition tends to present after age 50 years old, with presence of both pseudoexfoliative material and pigment dispersion signs. The pigment dispersion syndrome may be quiescent at the time of pseudoexfoliation onset and may have gone undiagnosed. This form of glaucoma poses challenges in controlling intraocular pressure and may progress rapidly, often requiring surgical intervention.</p><p><strong>Summary: </strong>This paper reviews the common examination findings of pigment dispersion syndrome and pseudoexfoliation, which may aid clinicians in the diagnosis of the rare condition, overlap syndrome. The connection between the two conditions remains unclear, though studies of possible genetic associations are underway. The two-hit theory, or initial damage to the trabecular meshwork increasing susceptibility to future damage, is plausible given the severe nature of the condition. Though definitive conclusions regarding treatment strategies and outcomes of overlap syndrome are lacking, increased awareness, diagnosis, and study of the condition may help guide the management of overlap syndrome.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"122-129"},"PeriodicalIF":3.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142607464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosing glaucoma progression with optical coherence tomography. 利用光学相干断层扫描诊断青光眼进展。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-03-01 Epub Date: 2024-11-07 DOI: 10.1097/ICU.0000000000001106
Laura D Palmer, Atalie C Thompson, Sanjay Asrani

Purpose of review: Optical coherence tomography (OCT) is a widely used tool to diagnose and monitor glaucoma by objectively measuring the ganglion cell layer and the retinal nerve fiber layer (RNFL) thickness. The presence of RNFL thinning raises suspicion for glaucoma progression. Therefore, this review aims to discuss current approaches to using OCT for detecting glaucomatous change, limitations, and recent advancements.

Recent findings: Previously established approaches to determining glaucomatous progression on OCT include quantitative and qualitative methods. The most common quantitative methods include event-based and trend-based analysis. Decreasing RNFL thickness or loss of the ganglion cell layer are indicative of glaucomatous changes. However, interpretation of OCT scans is strongly impacted by artifacts, which can be because of epiretinal membrane or posterior vitreous detachment. Race and aging also may impact interpretation of RNFL progression. More recent research focuses on loss of the RNFL because of the effects of systemic conditions. Given the limitations in the current approaches, recent advancements indicate a promising role for artificial intelligence in determining true glaucomatous progression.

Summary: This review highlights current approaches to identifying glaucoma progression on OCT, limitations to these approaches, and the potential role for artificial intelligence.

审查目的:光学相干断层扫描(OCT)通过客观测量神经节细胞层和视网膜神经纤维层(RNFL)的厚度,是诊断和监测青光眼的一种广泛应用的工具。如果出现 RNFL 变薄,则需要怀疑青光眼的进展。因此,本综述旨在讨论目前使用 OCT 检测青光眼变化的方法、局限性和最新进展:以前确定 OCT 青光眼进展的方法包括定量和定性方法。最常见的定量方法包括基于事件的分析和基于趋势的分析。RNFL 厚度的减少或神经节细胞层的丧失是青光眼变化的标志。然而,OCT 扫描的判读受到伪影的严重影响,伪影可能是由于视网膜外膜或玻璃体后脱离造成的。种族和年龄也会影响对 RNFL 进展的解读。最近的研究主要集中在 RNFL 因全身性疾病而造成的损失。鉴于当前方法的局限性,最近的进展表明人工智能在确定真正的青光眼进展方面大有可为。摘要:本综述重点介绍了当前在 OCT 上识别青光眼进展的方法、这些方法的局限性以及人工智能的潜在作用。
{"title":"Diagnosing glaucoma progression with optical coherence tomography.","authors":"Laura D Palmer, Atalie C Thompson, Sanjay Asrani","doi":"10.1097/ICU.0000000000001106","DOIUrl":"10.1097/ICU.0000000000001106","url":null,"abstract":"<p><strong>Purpose of review: </strong>Optical coherence tomography (OCT) is a widely used tool to diagnose and monitor glaucoma by objectively measuring the ganglion cell layer and the retinal nerve fiber layer (RNFL) thickness. The presence of RNFL thinning raises suspicion for glaucoma progression. Therefore, this review aims to discuss current approaches to using OCT for detecting glaucomatous change, limitations, and recent advancements.</p><p><strong>Recent findings: </strong>Previously established approaches to determining glaucomatous progression on OCT include quantitative and qualitative methods. The most common quantitative methods include event-based and trend-based analysis. Decreasing RNFL thickness or loss of the ganglion cell layer are indicative of glaucomatous changes. However, interpretation of OCT scans is strongly impacted by artifacts, which can be because of epiretinal membrane or posterior vitreous detachment. Race and aging also may impact interpretation of RNFL progression. More recent research focuses on loss of the RNFL because of the effects of systemic conditions. Given the limitations in the current approaches, recent advancements indicate a promising role for artificial intelligence in determining true glaucomatous progression.</p><p><strong>Summary: </strong>This review highlights current approaches to identifying glaucoma progression on OCT, limitations to these approaches, and the potential role for artificial intelligence.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"130-134"},"PeriodicalIF":3.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142607463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reporting outcomes of minimally invasive glaucoma surgery. 报告微创青光眼手术的结果。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-03-01 Epub Date: 2024-10-28 DOI: 10.1097/ICU.0000000000001100
Naomi E Gutkind, Steven J Gedde

Purpose of review: This review presents guidelines for designing studies and reporting efficacy and safety outcomes in minimally invasive glaucoma surgery (MIGS) research.

Recent findings: Adherence to reporting guidelines in MIGS studies is crucial for providers and patients to appraise surgical options. Recent guidelines have outlined appropriate methodology, efficacy outcomes, and safety reporting, so that study results are presented in an interpretable and uniform manner.

Summary: MIGS are changing the glaucoma treatment paradigm by offering safer, less invasive alternatives to traditional filtering surgery. However, inconsistent reporting of outcomes in MIGS trials hampers comparison and clinical decision-making. Recent guidelines have aimed to highlight appropriate methodology and encourage standardization in reporting outcomes to improve the quality of MIGS literature. Key considerations include defining baseline intraocular pressure, reporting standardized demographic data, using consistent endpoints, presenting standardized figures, evaluating medication use, and documenting adverse events. By adhering to these guidelines, MIGS trials can offer clearer insights into surgical outcomes, aiding both surgeons and patients in treatment decisions.

综述目的:本综述介绍了微创青光眼手术(MIGS)研究中设计研究和报告疗效与安全性结果的指南:遵守微创青光眼手术研究的报告指南对于医疗机构和患者评估手术方案至关重要。摘要:微创青光眼手术为传统滤过手术提供了更安全、创伤更小的替代方案,从而改变了青光眼治疗模式。然而,MIGS 试验结果报告的不一致妨碍了比较和临床决策。近期的指南旨在强调适当的方法并鼓励结果报告的标准化,以提高 MIGS 文献的质量。主要考虑因素包括定义基线眼压、报告标准化的人口统计学数据、使用一致的终点、呈现标准化的数字、评估药物使用情况以及记录不良事件。通过遵守这些准则,MIGS 试验可以更清楚地了解手术效果,帮助外科医生和患者做出治疗决定。
{"title":"Reporting outcomes of minimally invasive glaucoma surgery.","authors":"Naomi E Gutkind, Steven J Gedde","doi":"10.1097/ICU.0000000000001100","DOIUrl":"10.1097/ICU.0000000000001100","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review presents guidelines for designing studies and reporting efficacy and safety outcomes in minimally invasive glaucoma surgery (MIGS) research.</p><p><strong>Recent findings: </strong>Adherence to reporting guidelines in MIGS studies is crucial for providers and patients to appraise surgical options. Recent guidelines have outlined appropriate methodology, efficacy outcomes, and safety reporting, so that study results are presented in an interpretable and uniform manner.</p><p><strong>Summary: </strong>MIGS are changing the glaucoma treatment paradigm by offering safer, less invasive alternatives to traditional filtering surgery. However, inconsistent reporting of outcomes in MIGS trials hampers comparison and clinical decision-making. Recent guidelines have aimed to highlight appropriate methodology and encourage standardization in reporting outcomes to improve the quality of MIGS literature. Key considerations include defining baseline intraocular pressure, reporting standardized demographic data, using consistent endpoints, presenting standardized figures, evaluating medication use, and documenting adverse events. By adhering to these guidelines, MIGS trials can offer clearer insights into surgical outcomes, aiding both surgeons and patients in treatment decisions.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"140-145"},"PeriodicalIF":3.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is minimally invasive glaucoma surgery killing trabeculectomies? 微创青光眼手术会杀死小梁切除术吗?
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-03-01 Epub Date: 2024-11-13 DOI: 10.1097/ICU.0000000000001108
Seng Chee Loon, Bryan Chin Hou Ang, Andrew White

Purpose of review: The introduction of minimally invasive glaucoma surgery (MIGS) has changed the surgical landscape of glaucoma surgery. For more than four decades, the most commonly performed glaucoma surgery around the world has been the trabeculectomy. This article examines whether trabeculectomy is still the predominant procedure in glaucoma today, in the context of rapidly emerging MIGS devices and procedures.

Recent findings: There is a growing trend of mild to moderate glaucoma cases undergoing MIGS procedures instead of trabeculectomy. Glaucoma drainage device implantation may also have taken away a significant share of the filtering surgery performed for more severe glaucoma. In addition, the availability and economics of implants has an influence on the prevalence of trabeculectomy.

Summary: Currently, trabeculectomy surgery is still the most common glaucoma surgery performed around the world. However, the proportion of glaucoma surgeries undergoing MIGS is increasing rapidly.

综述目的:微创青光眼手术(MIGS)的引入改变了青光眼手术的手术格局。四十多年来,世界上最常见的青光眼手术是小梁切除术。这篇文章探讨了小梁切除术是否仍然是当今青光眼的主要手术,在快速出现的MIGS设备和手术的背景下。最近的发现:越来越多的轻中度青光眼患者选择MIGS手术而不是小梁切除术。青光眼引流装置植入术也可能减少了较为严重的青光眼的滤过手术。此外,植入物的可用性和经济性对小梁切除术的流行率也有影响。摘要:目前,小梁切除术仍然是世界范围内最常见的青光眼手术。然而,青光眼手术采用MIGS的比例正在迅速增加。
{"title":"Is minimally invasive glaucoma surgery killing trabeculectomies?","authors":"Seng Chee Loon, Bryan Chin Hou Ang, Andrew White","doi":"10.1097/ICU.0000000000001108","DOIUrl":"10.1097/ICU.0000000000001108","url":null,"abstract":"<p><strong>Purpose of review: </strong>The introduction of minimally invasive glaucoma surgery (MIGS) has changed the surgical landscape of glaucoma surgery. For more than four decades, the most commonly performed glaucoma surgery around the world has been the trabeculectomy. This article examines whether trabeculectomy is still the predominant procedure in glaucoma today, in the context of rapidly emerging MIGS devices and procedures.</p><p><strong>Recent findings: </strong>There is a growing trend of mild to moderate glaucoma cases undergoing MIGS procedures instead of trabeculectomy. Glaucoma drainage device implantation may also have taken away a significant share of the filtering surgery performed for more severe glaucoma. In addition, the availability and economics of implants has an influence on the prevalence of trabeculectomy.</p><p><strong>Summary: </strong>Currently, trabeculectomy surgery is still the most common glaucoma surgery performed around the world. However, the proportion of glaucoma surgeries undergoing MIGS is increasing rapidly.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"146-151"},"PeriodicalIF":3.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimally invasive glaucoma surgery in angle closure. 微创青光眼闭角手术。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-03-01 Epub Date: 2024-12-18 DOI: 10.1097/ICU.0000000000001117
Nicole Shu-Wen Chan, Chelvin C A Sng

Purpose of review: This review discusses the evidence on the efficacy, safety and role of minimally invasive glaucoma surgery (MIGS) in eyes with angle closure glaucoma. While cataract surgery remains the most established surgical treatment for primary angle closure glaucoma (PACG), the intraocular pressure (IOP) may remain elevated after cataract surgery despite open angles due to trabecular meshwork damage from chronic iridotrabecular contact.

Recent findings: There is emerging evidence that combining cataract surgery with MIGS in eyes with PACG, though an off-label indication for some MIGS devices, can achieve greater IOP and glaucoma medication reduction than cataract surgery alone.

Summary: Trabecular bypass MIGS procedures and less destructive forms of ciliary body treatment have been shown to be effective in PACG and are safer alternatives to traditional incisional surgeries. Evidence for the use of subconjunctival MIGS and suprachoroidal MIGS in angle closure eyes is lacking at present, and further investigation is indicated.

综述目的:本文综述了微创青光眼手术(MIGS)治疗闭角型青光眼的疗效、安全性和作用。虽然白内障手术仍然是原发性闭角型青光眼(PACG)最成熟的手术治疗方法,但由于虹膜小梁接触造成的小梁网损伤,白内障手术后的眼内压(IOP)可能仍然升高,尽管角度开放。最近的发现:越来越多的证据表明,在患有PACG的眼睛中联合白内障手术和MIGS,尽管一些MIGS设备的适应症超出了说明书,但与单独白内障手术相比,可以实现更大的IOP和青光眼药物治疗。摘要:小梁旁路MIGS手术和破坏性较小的睫状体治疗形式已被证明对PACG有效,是传统切口手术更安全的选择。结膜下MIGS和脉络膜上MIGS在闭角眼中的应用目前尚缺乏证据,需要进一步的研究。
{"title":"Minimally invasive glaucoma surgery in angle closure.","authors":"Nicole Shu-Wen Chan, Chelvin C A Sng","doi":"10.1097/ICU.0000000000001117","DOIUrl":"10.1097/ICU.0000000000001117","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review discusses the evidence on the efficacy, safety and role of minimally invasive glaucoma surgery (MIGS) in eyes with angle closure glaucoma. While cataract surgery remains the most established surgical treatment for primary angle closure glaucoma (PACG), the intraocular pressure (IOP) may remain elevated after cataract surgery despite open angles due to trabecular meshwork damage from chronic iridotrabecular contact.</p><p><strong>Recent findings: </strong>There is emerging evidence that combining cataract surgery with MIGS in eyes with PACG, though an off-label indication for some MIGS devices, can achieve greater IOP and glaucoma medication reduction than cataract surgery alone.</p><p><strong>Summary: </strong>Trabecular bypass MIGS procedures and less destructive forms of ciliary body treatment have been shown to be effective in PACG and are safer alternatives to traditional incisional surgeries. Evidence for the use of subconjunctival MIGS and suprachoroidal MIGS in angle closure eyes is lacking at present, and further investigation is indicated.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"152-158"},"PeriodicalIF":3.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142856519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical pearls from glaucoma clinical trials: a case-based approach. 青光眼临床试验的临床珍珠:基于病例的方法。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-03-01 Epub Date: 2024-11-20 DOI: 10.1097/ICU.0000000000001113
Laura E Barna, In Young Chung, Lucy Q Shen
{"title":"Clinical pearls from glaucoma clinical trials: a case-based approach.","authors":"Laura E Barna, In Young Chung, Lucy Q Shen","doi":"10.1097/ICU.0000000000001113","DOIUrl":"10.1097/ICU.0000000000001113","url":null,"abstract":"","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"99-106"},"PeriodicalIF":3.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Foundation models in ophthalmology: opportunities and challenges. 眼科基础模式:机遇与挑战。
IF 2.6 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2024-11-04 DOI: 10.1097/ICU.0000000000001091
Mertcan Sevgi, Eden Ruffell, Fares Antaki, Mark A Chia, Pearse A Keane

Purpose of review: Last year marked the development of the first foundation model in ophthalmology, RETFound, setting the stage for generalizable medical artificial intelligence (GMAI) that can adapt to novel tasks. Additionally, rapid advancements in large language model (LLM) technology, including models such as GPT-4 and Gemini, have been tailored for medical specialization and evaluated on clinical scenarios with promising results. This review explores the opportunities and challenges for further advancements in these technologies.

Recent findings: RETFound outperforms traditional deep learning models in specific tasks, even when only fine-tuned on small datasets. Additionally, LMMs like Med-Gemini and Medprompt GPT-4 perform better than out-of-the-box models for ophthalmology tasks. However, there is still a significant deficiency in ophthalmology-specific multimodal models. This gap is primarily due to the substantial computational resources required to train these models and the limitations of high-quality ophthalmology datasets.

Summary: Overall, foundation models in ophthalmology present promising opportunities but face challenges, particularly the need for high-quality, standardized datasets for training and specialization. Although development has primarily focused on large language and vision models, the greatest opportunities lie in advancing large multimodal models, which can more closely mimic the capabilities of clinicians.

回顾的目的:去年,眼科领域开发出首个基础模型 RETFound,为可适应新任务的通用医学人工智能(GMAI)奠定了基础。此外,包括 GPT-4 和 Gemini 等模型在内的大型语言模型(LLM)技术也取得了突飞猛进的发展,这些模型已针对医学专业进行了定制,并在临床场景中进行了评估,取得了可喜的成果。本综述探讨了这些技术进一步发展的机遇和挑战:RETFound 在特定任务中的表现优于传统的深度学习模型,即使仅在小型数据集上进行微调也是如此。此外,Med-Gemini 和 Medprompt GPT-4 等 LMM 在眼科任务中的表现优于开箱即用的模型。然而,眼科专用的多模态模型仍然存在很大的不足。总结:总体而言,眼科基础模型带来了良好的机遇,但也面临着挑战,特别是需要高质量、标准化的数据集来进行训练和专业化。虽然开发工作主要集中在大型语言和视觉模型上,但最大的机遇在于推进大型多模态模型的开发,因为这些模型能更接近临床医生的能力。
{"title":"Foundation models in ophthalmology: opportunities and challenges.","authors":"Mertcan Sevgi, Eden Ruffell, Fares Antaki, Mark A Chia, Pearse A Keane","doi":"10.1097/ICU.0000000000001091","DOIUrl":"10.1097/ICU.0000000000001091","url":null,"abstract":"<p><strong>Purpose of review: </strong>Last year marked the development of the first foundation model in ophthalmology, RETFound, setting the stage for generalizable medical artificial intelligence (GMAI) that can adapt to novel tasks. Additionally, rapid advancements in large language model (LLM) technology, including models such as GPT-4 and Gemini, have been tailored for medical specialization and evaluated on clinical scenarios with promising results. This review explores the opportunities and challenges for further advancements in these technologies.</p><p><strong>Recent findings: </strong>RETFound outperforms traditional deep learning models in specific tasks, even when only fine-tuned on small datasets. Additionally, LMMs like Med-Gemini and Medprompt GPT-4 perform better than out-of-the-box models for ophthalmology tasks. However, there is still a significant deficiency in ophthalmology-specific multimodal models. This gap is primarily due to the substantial computational resources required to train these models and the limitations of high-quality ophthalmology datasets.</p><p><strong>Summary: </strong>Overall, foundation models in ophthalmology present promising opportunities but face challenges, particularly the need for high-quality, standardized datasets for training and specialization. Although development has primarily focused on large language and vision models, the greatest opportunities lie in advancing large multimodal models, which can more closely mimic the capabilities of clinicians.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"90-98"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620320/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142331709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global prevalence of cataract surgery. 白内障手术的全球患病率。
IF 2.6 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2024-09-25 DOI: 10.1097/ICU.0000000000001092
Hassan Hashemi, Faezeh Fayaz, Alireza Hashemi, Mehdi Khabazkhoob

Purpose of review: The objective of this review article is to ascertain the global distribution of cataract surgery and evaluate the extent of its coverage in recent years.

Recent findings: The cataract surgical rate (CSR) has been reported from 36 to 12 800 (per million population) across different countries. The average cataract surgical coverage (CSC) in the majority of countries was around 50% or lower. Additionally, in many countries, the efficient CSC (eCSC) deviates from the CSC, emphasizing the importance of attention to the quality of surgical procedures. Socioeconomic status and access to health services are key determinants in the distribution of cataract surgery. This procedure is more prevalent among older individuals, with a higher incidence among men and private insurances tend to cover a larger portion of cataract surgeries. The pandemic of COVID-19 has had a detrimental effect on cataract surgery rates in numerous countries.

Summary: The rate of cataract surgery and its extent of coverage in certain countries is inadequate. The primary factor influencing the quantity and coverage of cataract surgeries is the economic status of the countries. Additionally, government support through insurance and the provision of appropriate healthcare services can contribute to an increase in cataract surgeries.

综述目的:本综述的目的是确定白内障手术的全球分布,并评估近年来白内障手术的覆盖范围。最近的发现:据报道,不同国家的白内障手术率(CSR)从每百万人36例到12800例不等。大多数国家的平均白内障手术覆盖率约为50%或更低。此外,在许多国家,高效CSC (eCSC)偏离了CSC,强调了关注外科手术质量的重要性。社会经济地位和获得保健服务的机会是白内障手术分布的关键决定因素。这种手术在老年人中更为普遍,男性的发病率更高,私人保险往往会支付更多的白内障手术费用。COVID-19大流行对许多国家的白内障手术率产生了不利影响。总结:在某些国家,白内障手术的普及率和覆盖范围都不够。影响白内障手术数量和覆盖率的主要因素是国家的经济状况。此外,政府通过保险和提供适当的保健服务提供的支持有助于白内障手术的增加。
{"title":"Global prevalence of cataract surgery.","authors":"Hassan Hashemi, Faezeh Fayaz, Alireza Hashemi, Mehdi Khabazkhoob","doi":"10.1097/ICU.0000000000001092","DOIUrl":"10.1097/ICU.0000000000001092","url":null,"abstract":"<p><strong>Purpose of review: </strong>The objective of this review article is to ascertain the global distribution of cataract surgery and evaluate the extent of its coverage in recent years.</p><p><strong>Recent findings: </strong>The cataract surgical rate (CSR) has been reported from 36 to 12 800 (per million population) across different countries. The average cataract surgical coverage (CSC) in the majority of countries was around 50% or lower. Additionally, in many countries, the efficient CSC (eCSC) deviates from the CSC, emphasizing the importance of attention to the quality of surgical procedures. Socioeconomic status and access to health services are key determinants in the distribution of cataract surgery. This procedure is more prevalent among older individuals, with a higher incidence among men and private insurances tend to cover a larger portion of cataract surgeries. The pandemic of COVID-19 has had a detrimental effect on cataract surgery rates in numerous countries.</p><p><strong>Summary: </strong>The rate of cataract surgery and its extent of coverage in certain countries is inadequate. The primary factor influencing the quantity and coverage of cataract surgeries is the economic status of the countries. Additionally, government support through insurance and the provision of appropriate healthcare services can contribute to an increase in cataract surgeries.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":"36 1","pages":"10-17"},"PeriodicalIF":2.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142786378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Opinion in Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1